Search alternatives:
point decrease » point increase (Expand Search)
men decrease » mean decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
point decrease » point increase (Expand Search)
men decrease » mean decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
-
1
-
2
Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease
Published 2020“…<b><i>Results:</i></b> Data from a total of 143 patients (median age, 42 years; 32 men and 111 women) were investigated. …”
-
3
-
4
NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways.
Published 2020“…(C) <i>psid-D4</i> clones in wing disc, marked by GFP expression (pointed by arrowheads), showed decreased MAPK level. …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…<p>(A) RFF is decreased by alterations in heart rate. …”
-
12
-
13
Decreased macrophage recruitment correlates with decreased angiogenesis.
Published 2013“…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
-
14
-
15
-
16
-
17
Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis
Published 2017“…</p><p>Results</p><p>1 SD genetically instrumented increase in BMI was associated with a 0.25 SD decrease in serum testosterone (IV ratio: -0.25, 95% CI: -0.42–-0.09, p = 2.8*10<sup>−3</sup>). …”
-
18
-
19
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
20